These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 30054967)

  • 1. Outcomes of using flash glucose monitoring technology by children and young people with type 1 diabetes in a single arm study.
    Campbell FM; Murphy NP; Stewart C; Biester T; Kordonouri O
    Pediatr Diabetes; 2018 Nov; 19(7):1294-1301. PubMed ID: 30054967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-adjunctive flash glucose monitoring system use during summer-camp in children with type 1 diabetes: The free-summer study.
    Piona C; Dovc K; Mutlu GY; Grad K; Gregorc P; Battelino T; Bratina N
    Pediatr Diabetes; 2018 Nov; 19(7):1285-1293. PubMed ID: 30022571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial.
    Oskarsson P; Antuna R; Geelhoed-Duijvestijn P; Krӧger J; Weitgasser R; Bolinder J
    Diabetologia; 2018 Mar; 61(3):539-550. PubMed ID: 29273897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial.
    Haak T; Hanaire H; Ajjan R; Hermanns N; Riveline JP; Rayman G
    Diabetes Ther; 2017 Feb; 8(1):55-73. PubMed ID: 28000140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Reduced Self-Monitored Blood Glucose Testing After Adoption of Continuous Glucose Monitoring on Hemoglobin A1c and Time in Range.
    Puhr S; Calhoun P; Welsh JB; Walker TC
    Diabetes Technol Ther; 2018 Aug; 20(8):557-560. PubMed ID: 30036082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flash glucose monitoring helps achieve better glycemic control than conventional self-monitoring of blood glucose in non-insulin-treated type 2 diabetes: a randomized controlled trial.
    Wada E; Onoue T; Kobayashi T; Handa T; Hayase A; Ito M; Furukawa M; Okuji T; Okada N; Iwama S; Sugiyama M; Tsunekawa T; Takagi H; Hagiwara D; Ito Y; Suga H; Banno R; Kuwatsuka Y; Ando M; Goto M; Arima H
    BMJ Open Diabetes Res Care; 2020 Jun; 8(1):. PubMed ID: 32518063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes.
    Haak T; Hanaire H; Ajjan R; Hermanns N; Riveline JP; Rayman G
    Diabetes Ther; 2017 Jun; 8(3):573-586. PubMed ID: 28401454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy, satisfaction and usability of a flash glucose monitoring system among children and adolescents with type 1 diabetes attending a summer camp.
    Hansen EA; Klee P; Dirlewanger M; Bouthors T; Elowe-Gruau E; Stoppa-Vaucher S; Phan-Hug F; Antoniou MC; Pasquier J; Dwyer AA; Pitteloud N; Hauschild M
    Pediatr Diabetes; 2018 Nov; 19(7):1276-1284. PubMed ID: 30014625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial.
    Forlenza GP; Li Z; Buckingham BA; Pinsker JE; Cengiz E; Wadwa RP; Ekhlaspour L; Church MM; Weinzimer SA; Jost E; Marcal T; Andre C; Carria L; Swanson V; Lum JW; Kollman C; Woodall W; Beck RW
    Diabetes Care; 2018 Oct; 41(10):2155-2161. PubMed ID: 30089663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Sensor-Augmented Pump Therapy with Predictive Low-Glucose Suspend Function on Glycemic Control and Patient Satisfaction in Adults and Children with Type 1 Diabetes.
    Beato-Víbora PI; Quirós-López C; Lázaro-Martín L; Martín-Frías M; Barrio-Castellanos R; Gil-Poch E; Arroyo-Díez FJ; Giménez-Álvarez M
    Diabetes Technol Ther; 2018 Nov; 20(11):738-743. PubMed ID: 30256132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the FreeStyle Libre™ flash glucose monitoring system on glycemic control in individuals with type 2 diabetes treated with basal-bolus insulin therapy: An open label, prospective, multicenter trial in Japan.
    Ogawa W; Hirota Y; Osonoi T; Tosaki T; Kato Y; Utsunomiya K; Nishimura R; Nakamura J
    J Diabetes Investig; 2021 Jan; 12(1):82-90. PubMed ID: 32562376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in Psychosocial Outcomes in Children with Type 1 Diabetes and Their Parents Following Subsidy for Continuous Glucose Monitoring.
    Burckhardt MA; Abraham MB; Mountain J; Coenen D; Paniora J; Clapin H; Jones TW; Davis EA
    Diabetes Technol Ther; 2019 Oct; 21(10):575-580. PubMed ID: 31335192
    [No Abstract]   [Full Text] [Related]  

  • 13. Accuracy, User Acceptability, and Safety Evaluation for the FreeStyle Libre Flash Glucose Monitoring System When Used by Pregnant Women with Diabetes.
    Scott EM; Bilous RW; Kautzky-Willer A
    Diabetes Technol Ther; 2018 Mar; 20(3):180-188. PubMed ID: 29470094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls.
    Nathanson D; Svensson AM; Miftaraj M; Franzén S; Bolinder J; Eeg-Olofsson K
    Diabetologia; 2021 Jul; 64(7):1595-1603. PubMed ID: 33774713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.
    van Beers CA; DeVries JH; Kleijer SJ; Smits MM; Geelhoed-Duijvestijn PH; Kramer MH; Diamant M; Snoek FJ; Serné EH
    Lancet Diabetes Endocrinol; 2016 Nov; 4(11):893-902. PubMed ID: 27641781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An alternative sensor-based method for glucose monitoring in children and young people with diabetes.
    Edge J; Acerini C; Campbell F; Hamilton-Shield J; Moudiotis C; Rahman S; Randell T; Smith A; Trevelyan N
    Arch Dis Child; 2017 Jun; 102(6):543-549. PubMed ID: 28137708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences for Percentage Times in Glycemic Range Between Continuous Glucose Monitoring and Capillary Blood Glucose Monitoring in Adults with Type 1 Diabetes: Analysis of the REPLACE-BG Dataset.
    Avari P; Uduku C; George D; Herrero P; Reddy M; Oliver N
    Diabetes Technol Ther; 2020 Mar; 22(3):222-227. PubMed ID: 31613142
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of predicted low suspend pump treatment on improving glycaemic control and quality of sleep in children with type 1 diabetes and their caregivers: the QUEST randomized crossover study.
    Schierloh U; Aguayo GA; Fichelle M; De Melo Dias C; Celebic A; Vaillant M; Barnard K; Cohen O; de Beaufort C
    Trials; 2018 Dec; 19(1):665. PubMed ID: 30509293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial.
    Bolinder J; Antuna R; Geelhoed-Duijvestijn P; Kröger J; Weitgasser R
    Lancet; 2016 Nov; 388(10057):2254-2263. PubMed ID: 27634581
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.